Health Care

2700 posts

Meet the micro-cap biotech company reinventing regenerative medicine

An in-depth analysis of NurExone Biologic, a pre-clinical company ushering regenerative medicine into its next era of growth.

Buzz on the Bullboards: Where quarterly reports meet business outlooks

Canadian equities have experienced a volatile stretch over the past week, with both the TSX Composite...

BriaCell receives FDA green light to advance breast cancer immunotherapy

BriaCell Therapeutics (NASDAQ:BCTX) got FDA approval for clinical trials of a new off-the-shelf immunotherapy for metastatic breast cancer.

Cannabix delivers marijuana breath test to Eastern Canada workplace testing clinic

Cannabix Technologies (CSE:BLO) delivered its Marijuana Breath Test devices to a workplace drug and alcohol testing clinic in eastern Canada.

Biotech company patenting world’s first AI voice test for substance abuse

Biotech company MindBio files a patent application for the world's first AI model to detect substance abuse though vocal analysis.

2 biotech stocks bridging the gap between unmet need and next-gen medicine

Exploring Lunai Bioworks and TheraCryf, two biotech stocks taking early strides towards improving the lives of tens of millions of patients.

Marvel Biosciences advancing autism drug for children

Marvel Biosciences announces two pediatric-friendly versions of its drug candidate, MB-204, which may help to treat autism and depression.

Voice is becoming the new frontier in safety AI

MindBio Therapeutics (CSE:MBIO) is a biotechnology and applied AI company commercializing proprietary voice analytics technology.

Buzz on the Bullboards: Return trajectories vs emerging threats

Global markets entered this week uneasy, as geopolitics once again took centre stage. Traders brace for volatility tied to Middle East.

MindBio completes development of platform for voice‑based intoxication detection

MindBio (CSE:MBIO) launched Intox Collect, expanding and accelerating voice based data collection for detecting drug and alcohol impairment.
NurExone Biologic Inc

NurExone Biologic: Beneficiary of US legislative change on stem cell therapy?

© 2026 Dr. Reuter Investor Relations. Article written by Sabine Lembert. All rights reserved. Stem cells are among the great...

Soleno Therapeutics shares jump nearly 40% on $2.9 billion takeout deal

Soleno Therapeutics (NASDAQ:SLNO) shares rallied after Neurocrine Biosciences agreed to acquire the company for US$2.9 billion.

Cannabix Technologies scores first marijuana breath test sales to construction sector

Cannabix Technologies (CSE:BLO) completed its first commercial sale of its Marijuana Breath Test system to a major construction company.

Dream Water Kids Sleep Gummies set for US summer debut

Delivra Health (TSXV:DHB) will launch a new line of kids sleep gummies under its Dream Water brand across the US market this June.

Buzz on the Bullboards: Oil shock, biotech breakthroughs and new tech

Global equities lurched from rally to rout since the U.S.–Israel strikes on Iran ignited a regional war and shutdown of the Strait of Hormuz.

Quit smoking with psychedelics? A new frontier for treatment — and investors

A new Johns Hopkins study found that a single dose of psilocybin, combined with therapy, helped smokers stay cigarette free at six months.

New bladder cancer drug may sharpen radiation’s aim

Theralase Technologies proves that its Rutherrin drug holds the potential to enhance radiation against non-muscle invasive bladder cancer.